We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $38.6B
1-Year Est. Return 45.89%
This Fund
S&P 500
This Quarter Est. Return
-2.52%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.56%
5 Year Est. Return
+159.19%
10 Year Est. Return
+649.1%
AUM
$64.7B
AUM Growth
-$40.4B
Cap. Flow
-$27.6B
Cap. Flow %
-42.63%
Top 10 Hldgs %
26.85%
Holding
3,630
New
755
Increased
1,196
Reduced
887
Closed
544

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$484M
2
TSLA icon
Tesla
TSLA
+$141M
3
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$71M
4
BA icon
Boeing
BA
+$56.5M
5
ADBE icon
Adobe
ADBE
+$51.1M

Sector Composition

Rank Sector Weight
1 Technology 0.95%
2 Healthcare 0.89%
3 Consumer Discretionary 0.7%
4 Financials 0.45%
5 Energy 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
2976
Accenture
ACN
$108B
-2,660
Closed -$769K
ACVA icon
2977
CALL
ACV Auctions
ACVA
$1.3B
-97,600
Closed -$638K
AEO icon
2978
American Eagle Outfitters
AEO
$3.01B
$0 ﹤0.01%
+6
New +$70
AES icon
2979
AES
AES
$10.5B
-2,370
Closed -$56.2K
AG icon
2980
First Majestic Silver
AG
$9.07B
-49,751
Closed -$371K
AGIO icon
2981
Agios Pharmaceuticals
AGIO
$1.93B
$0 ﹤0.01%
2
-137,229
-100% -$3.68M
AGO icon
2982
Assured Guaranty
AGO
$3.34B
-14,095
Closed -$786K
AGO icon
2983
PUT
Assured Guaranty
AGO
$3.34B
-96,500
Closed -$5.38M
AI icon
2984
C3.ai
AI
$1.59B
-7,494
Closed -$134K
AIZ icon
2985
CALL
Assurant
AIZ
$14.3B
-14,500
Closed -$2.51M
AKBA icon
2986
Akebia Therapeutics
AKBA
$252M
-109,683
Closed -$39K
ALNY icon
2987
Alnylam Pharmaceuticals
ALNY
$29.3B
-12,781
Closed -$1.86M
AMC icon
2988
CALL
AMC Entertainment Holdings
AMC
$2.31B
-48,250
Closed -$6.54M
AMC icon
2989
AMC Entertainment Holdings
AMC
$2.31B
$0 ﹤0.01%
3
-6,717
-100% -$918K
AMPH icon
2990
PUT
Amphastar Pharmaceuticals
AMPH
$916M
-100,000
Closed -$3.48M
AMRN
2991
Amarin Corp
AMRN
$303M
-2,011
Closed -$60K
AMT icon
2992
American Tower
AMT
$80.4B
-2,239
Closed -$575K
ANF icon
2993
CALL
Abercrombie & Fitch
ANF
$5B
-124,100
Closed -$2.1M
ANF icon
2994
PUT
Abercrombie & Fitch
ANF
$5B
-25,000
Closed -$423K
APLS
2995
CALL
DELISTED
Apellis Pharmaceuticals
APLS
-135,700
Closed -$6.14M
ARE icon
2996
CALL
Alexandria Real Estate Equities
ARE
$8.56B
-158,000
Closed -$22.9M
ARE icon
2997
PUT
Alexandria Real Estate Equities
ARE
$8.56B
-100
Closed -$15K
ARGX icon
2998
CALL
argenx
ARGX
$54.1B
-10,000
Closed -$3.79M
ARI
2999
CALL
Apollo Commercial Real Estate
ARI
$885M
-200
Closed -$2K
ARKG icon
3000
ARK Genomic Revolution ETF
ARKG
$1.73B
$0 ﹤0.01%
1
-170,565
-100% -$6.26M

Similar funds

Parallax Volatility Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Parallax Volatility Advisers held 3,630 positions worth $64.7B, down 38% from $105B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Parallax Volatility Advisers withdrew a net $27.6B in Q3 2022, closing 544 positions and reducing 887 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $31.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 0.95% of assets, up from 0.44% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Parallax Volatility Advisers opened a new position in Walt Disney worth $62.3M.

  • Parallax Volatility Advisers's largest Q3 2022 buy was Walt Disney: 659,918 shares worth $62.3M.
  • Parallax Volatility Advisers added most to Invesco QQQ Trust in Q3 2022, an estimated $458M increase.
  • Parallax Volatility Advisers's biggest Q3 2022 reduction was GSK, cutting an estimated $484M.
  • Parallax Volatility Advisers fully exited Berkshire Hathaway Class B in Q3 2022, selling an estimated $31.3M.
  • Parallax Volatility Advisers's ten largest holdings make up 27% of its $64.7B portfolio in Q3 2022.
  • Parallax Volatility Advisers opened 755 new positions and closed 544 in Q3 2022.
  • Parallax Volatility Advisers's portfolio value fell 38% quarter-over-quarter to $64.7B.

Based on Parallax Volatility Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.